Literature DB >> 23560025

Author reply.

Girish Chandra Bhatt1, Tanya Sharma.   

Abstract

Entities:  

Year:  2012        PMID: 23560025      PMCID: PMC3611927     

Source DB:  PubMed          Journal:  J Pediatr Neurosci        ISSN: 1817-1745


× No keyword cloud information.
Dear Sir, We appreciate the interest shown in our case report[1] and the opportunity to clarify the queries raised by the authors.[2] While writing case report, one has to follow the journal's guidelines and it becomes difficult to provide very minute details such as date of admission and discharge of the patient. This patient was admitted to our hospital in July 2007[3] and rapid test for malaria was done on the 2nd day of admission (G0161 CareStart Malaria HRP2/PLDH (Pf/Pv) COMBO). We completely agree that the ‘gold standard’ is microscopy with a thin and thick smear for which National Vector Control Programme would have been more suitable. P. vivax and falciparum are the most prevalent species that cause malaria, and mixed infection of the two species are common and frequently recorded in the field survey,[4] but are underreported. A study revealed that 10.5% of the patients diagnosed with P. vivax alone actually harbored P. facliparum as well.[5] Indeed, the danger of misdiagnosing mixed infection as a single infection has been noticed by Knowles and White[6] who described the ‘flexible stopping rule’, the tendency of the worker to stop examining a blood film once parasite have been found. P. falciparum disease severity ranges from severe and complicated malaria to mild and uncomplicated, to asymptomatic.[7] In our case, we speculated Japanese Encephalitis Virus (JEV) as a cause of acute encephalitic syndrome (AES) as suggested by the clinical course of the disease. However, at times it becomes very difficult to clinically differentiate between the two due to overlapping clinical presentations.
  6 in total

Review 1.  Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster.

Authors: 
Journal:  Trans R Soc Trop Med Hyg       Date:  2000-04       Impact factor: 2.184

2.  Changing clinico-laboratory profile of encephalitis patients in the eastern Uttar Pradesh region of India.

Authors:  Girish Chandra Bhatt; V P Bondre; G N Sapkal; Tanya Sharma; Santosh Kumar; M M Gore; K P Kushwaha; A K Rathi
Journal:  Trop Doct       Date:  2012-04       Impact factor: 0.731

3.  Can treatment of P. vivax lead to a unexpected appearance of falciparum malaria?

Authors:  D P Mason; S Krudsood; P Wilairatana; P Viriyavejakul; U Silachamroon; W Chokejindachai; P Singhasivanon; S Supavej; F E McKenzie; S Looareesuwan
Journal:  Southeast Asian J Trop Med Public Health       Date:  2001-03       Impact factor: 0.267

4.  Hidden Plasmodium falciparum infections.

Authors:  S Krudsood; P Wilairatana; D P Mason; S Treeprasertsuk; P Singhasivanon; S Looareesuwan
Journal:  Southeast Asian J Trop Med Public Health       Date:  1999-12       Impact factor: 0.267

5.  Concurrent infection of Japanese encephalitis and mixed plasmodium infection.

Authors:  Girish Chandra Bhatt; Tanya Sharma; K P Kushwaha
Journal:  J Pediatr Neurosci       Date:  2012-01

6.  Concurrent infection of Japanese encephalitis and mixed plasmodium infection.

Authors:  Subhash C Arya; Nand L Kalra
Journal:  J Pediatr Neurosci       Date:  2012-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.